ddition, the company disclaims any obligation to update or correct any
forward-looking statements in all of the Company's press releases to
reflect events or circumstances after the date hereof.
For worldwide investor and media inquiries, please contact:
Starwood Research Institute
J Marks
Tel: +1-310-601-7080
Web: http://starwoodresearch.com
China Holdings Inc. (Las Vegas and Beijing)
Julianna Lu, Chief Executive Officer
Tel: +86-10-6586-4770; +86-10-6586-4790
Email: info@chinaholding.net; lujulianna@yahoo.com
Web: http://www.chinaholding.net
'/>"/>SOURCE China Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
China Display Technologies, Inc. to Present at Roth Conference2.
Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources3.
Wall Street Reporter Spotlights China Holdings Inc. and Asias Hunger for Alternative Energy4.
Chinas Environment, Health Examined in New Wilson Center Report5.
Red Cross Partners with YeePay on China Snow Disaster Relief6.
China Sky One Medical Raises $25 Million in Private Placement7.
DuPont Opens Fluoropolymer Production Plant in China8.
China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection9.
China Medical Technologies to Announce Financial Results for the Third Quarter Ended December 31, 2007 on February 28, 200810.
China Nepstar Chain Drugstore Launches Charitable Initiative to Promote Awareness of Low-income Working Womens Health Issues11.
Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries